Co-founder & VP – Vector Design, Infinitopes Cancer Vaccines | Honorary Researcher, Univ. of Oxford. Interests: multi-antigen vaccine designs & cancer vaccines
Oxford
Joined April 2012
- Tweets99
- Following798
- Followers220
- Likes613
Senthil Chinnakannan retweeted
We are recruiting TWO fantastic post doctoral scientists at Barnes Lab and @PKlenermanLab following a U19 award to develop novel HCV vaccines: 1) in advanced cellular immunology (attached) and 2) molecular vaccinology (vaccine design & generation) [to follow]. Great opportunity!
Senthil Chinnakannan retweeted
👩🔬 3,000 researchers
🙋 24,675 volunteers
🌎 Delivered to 170 countries
💉 300,000,000 doses worldwide
Today marks the one-year anniversary of the first dose of the #OxfordVaccine being given.
Here are some of the things we've done in that year:
Senthil Chinnakannan retweeted
In continuation of enhanced defence cooperation between 🇮🇳 and 🇧🇩, Indian Army gifts 10 Mine Detection Dogs (MDDs) to Bangladesh Army as a goodwill gesture at Petrapole-Benapole ICP in a ceremonial function.
@easterncomd
@adgpi
Senthil Chinnakannan retweeted
Our Our paper in pre-print: researchsquare.com/article/r…
Robust T cells after 2 doses of pfizer vaccine against variants of concern. But no neutralising Abs against B1.351 after one dose theguardian.com/world/2021/f…
Senthil Chinnakannan retweeted
90% efficacy at lower dose (= more available vaccine to vaccinate more people) plus 2-8 oC cold storage that can integrate into existing supply chains >> greater potential distribution.
All in 8 months?! Amazing work. And the result of decades of fundamental academic research!
Today marks an important milestone in the fight against #COVID19. Interim data show the #OxfordVaccine is 70.4% effective, & tests on two dose regimens show that it could be 90%, moving us one step closer to supplying it at low cost around the world>> bit.ly/oxford-vaccine-result…
Senthil Chinnakannan retweeted
I have a position in my group for a post-doc investigating host-virus genomics, based at Oxford University. Please pass it on to anyone who might be interested.
my.corehr.com/pls/uoxrecruit…
Senthil Chinnakannan retweeted
Hi Twitter! We're looking for an RA in my @vGlycoproteins lab. Starts ASAP, until Sept 2021, on a really cool Nipah vaccines project with @PRRS_Immunol. If you're interested in nAb responses, vaccine dev' and emerging diseases this IS the job! isw.changeworknow.co.uk/pirb…
Please RT
Senthil Chinnakannan retweeted
1) There is a lot of talk about decaying antibodies. I would like to walk you through a few findings about antibodies to SARS-CoV-2 that we put on medRxiv on Friday. Ill do this slowly over the day (while being in nonstop conference calls). But I feel this needs to get out there.
Senthil Chinnakannan retweeted
Oxford’s Covid-19 vaccine produces a good immune response, reveals new study.
Teams at @VaccineTrials and @OxfordVacGroup have found there were no safety concerns, and the vaccine stimulated strong immune responses: bit.ly/PhaseIResults
Senthil Chinnakannan retweeted
The #Ebola vaccine, tested and verified by the University of Oxford, has now been approved by the European Commission. Find out more about this incredible milestone in the fight against Ebola outbreaks: bit.ly/3inXmBx
Senthil Chinnakannan retweeted
Thanks leo! Class II invariant chain as a gentic adjuvant. Its a transferable technolgy to everyone who wants to enhance T cell immunity. Vaccines for cancer and infectious disease. 4 years of work+. Thanks to the whole team. – at Oxford, England
One of the most interesting things I have worked on and one of the bits of science I enjoyed the most is out now in @ScienceTM. Worth a read for anyone interested in T cells, vaccines, HCV or antigen presentation! 🤓🧬@EleanorBarnesOx @IlariaE09929587 stm.sciencemag.org/content/1…
Senthil Chinnakannan retweeted
Preclinical data showing promising immune responses and prevention of #Covid_19 pneumonia with @jennerinstitute
#vaccine
"ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques" biorxiv.org/content/10.1101/…
Senthil Chinnakannan retweeted
Happy 2nd Birthday, @conceptionxtech! What a journey. From a small pilot @UCLEngineering, we are now riding the wave of #deeptech innovation; propelling #PhDs from across the UK on their mission #venture scientists. All thanks to this wonderful team, our partners, and friends!
Senthil Chinnakannan retweeted
COVID Conversations research.ox.ac.uk/Article/20…
Senthil Chinnakannan retweeted
Thanks mike..a super useful summay of the T cell literature. Can I request one weekly! – at Oxford, England
CD8+ T cells play an important role in clearing respiratory virus. I looked at 10 preprints from @biorxivpreprint and @medrxivpreprint all exploring T cell responses to #SARS2/#COVID19. In no particular order, here’s what I found interesting, and then some comments below. 1/17
Senthil Chinnakannan retweeted
ChAdOx1 vaccinations shown to be protective against MERS (another coronavirus) in NHPs and mice, with just one vaccination. This is timely and good news!!!
This Post is from an account that no longer exists. Learn more
Senthil Chinnakannan retweeted
The University has entered into a partnership with @AstraZeneca on the development and manufacture of the COVID-19 vaccine currently undergoing clinical trials at Oxford ox.ac.uk/news/2020-04-30-lan…
Senthil Chinnakannan retweeted
Landmark partnership announced for development of COVID-19 vaccine | University of Oxford ox.ac.uk/news/2020-04-30-lan…
Senthil Chinnakannan retweeted
We’re partnering with @AstraZeneca to ensure that our #COVID19 vaccine, if successful, can be manufactured & distributed to those who need it as quickly as possible.
This will be on a not-for-profit basis for the duration of the coronavirus pandemic:
bit.ly/35fiVhE